Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Gautier, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Gautier, J.-F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:1316-1317, 2003
© 2003 by the American Diabetes Association, Inc.


Letters: Observations
Letter

Glucose Response to Intense Aerobic Exercise in Type 1 Diabetes

Maintenance of near euglycemia despite a drastic decrease in insulin dose

Franck Mauvais-Jarvis, MD1, Eugène Sobngwi, MD1, Raphaël Porcher, PHD2, Jean Pierre Garnier, PHD3, Patrick Vexiau, MD1, Alain Duvallet, MD4 and Jean-François Gautier, MD, PHD1

1 Department of Endocrinology and Diabetes, Saint-Louis Hospital, Paris, France
2 Department of Biostatistics and Medical Informatics, Saint-Louis Hospital, Paris, France
3 Department of Biochemistry, Saint-Louis Hospital, AP-HP and Faculty of Pharmacy; University of Paris, Paris, France
4 Department of Exercise Physiology, University of Paris VII School of Medicine, Tarnier Hospital, Paris, France

In patients with type 1 diabetes, hypoglycemia or degradation in blood glucose control may occur during and after physical exercise (13). This may be avoided in patients with good glycemic control by decreasing insulin doses and/or ingesting carbohydrate. Although most sport activities involve intense muscle exercise, current recommendations are based on studies on moderate exercise (4). We therefore investigated the effect of a drastic reduction in insulin dose before a 60-min high-intensity cycle exercise in 12 subjects with uncomplicated type 1 diabetes (age 32 ± 7 years, BMI 23 ± 7 kg/m2, HbA1c 7.2 ± 3.8%, and VO2max 40 ± 27 ml · min-1 · kg-1 [mean ± SD]). Six patients were treated with three daily injections (regular insulin in the morning and at noon and mixed regular NPH insulin before dinner). The six remaining patients were treated with two daily injections (30% regular/70% NPH insulin). After determination of VO2max, patients reported to the laboratory on two separate occasions, 1 week apart, in randomized order 90 min after breakfast (60 g carbohydrates, 10 g lipids, and 8 g proteins) to perform a 60-min exercise session on an ergocycle at 70% VO2max. On one occasion, exercise was performed with the usual morning insulin dose. On the other, morning insulin dose was reduced by 90% for patients treated with three daily injections and by 50% for patients treated with two injections per day. Power output was monitored and strictly maintained during the tests to correspond to ~70% VO2max.

Changes in plasma glucose (PG) levels were analyzed by a mixed-model ANCOVA, with a random subject effect and random coefficients for time within each subject, using the SAS version 6.12 software package (SAS Institute, Cary, NC).

At the beginning of exercise and over the test period, PG levels were higher in the experimental condition with insulin dose reduction (P < 0.0001) (Fig. 1). Changes in PG levels were similar in both conditions during exercise and recovery (P = 0.99). No difference was observed when considering insulin regimen. During exercise, the mean decrease in PG concentrations was -0.085 ± 0.012 mmol · l-1 · min-1 (mean ± SE) (P < 0.0001), whereas no significant variation was observed during the recovery period. When exercise was performed without reducing insulin doses, eight patients (66%) had hypoglycemia and were given oral sucrose (22 ± 3 g). Changes in plasma lactate, growth hormone, cortisol, glucagon, and norepinephrine were not statistically different. The peak of plasma epinephrine concentration was higher in the test without insulin reduction: 2.3 ± 1.5 vs. 1.1 ± 0.7 nmol/l (P < 0.04, Student’s t test).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1— Changes in PG levels during exercise and recovery performed with ({blacksquare}) and without ({square}) insulin reduction. Of 12 patients, 8 received oral glucose during the condition without insulin reduction. Data are expressed as mean ± SE (n = 12).

 
In previous studies, decreasing insulin dose before moderate exercise (~55% VO2max) was not associated with degradation in blood glucose control during and after exercise (1,4,5). However, most sport activities, whether individual (running, biking, hiking, and swimming) or team (basketball, football, and handball) involve intense muscle exercise. We show here that a 90% reduction of morning regular insulin before intense exercise allows the maintenance of near normal blood glucose levels without occurrence of hypoglycemia. When insulin was not reduced, two-thirds of patients experienced hypoglycemia.

This study emphasizes the importance of insulin-independent contraction-induced glucose uptake by muscle, previously demonstrated in healthy men (6) and mice lacking muscle insulin receptor (rev. in 7).

In conclusion, we demonstrate that type 1 diabetic patients can perform intense muscle exercise after a 50–90% reduction in insulin dose, depending on their insulin regimen. This decrease prevents hypoglycemia without worsening metabolic control. Such advice could be given to young type 1 diabetic patients engaged in sports activities.

Footnotes

Address correspondence to Dr. Jean-François Gautier, Department of Endocrinology and Diabetes, Saint-Louis Hospital, 1, Avenue Claude Vellefaux, 75010 Paris, France. E-mail: j-fgautier{at}wanadoo.fr.

References

  1. Berger M, Berchtold P, Cuppers HJ, Drost H, Kley HK, Muller WA, Wiegelmann W, Zimmerman-Telschow H, Gries FA, Kruskemper HL, Zimmermann H: Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 13: 355–365, 1977[Medline]
  2. Koivisto VA, Felig P: Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med 298: 79–83, 1978[Abstract]
  3. Horton ES: Role and management of exercise in diabetes mellitus. Diabetes Care 11: 201–211, 1988[Abstract]
  4. Schiffrin A, Parikh S: Accommodating planned exercise in type I diabetic patients on intensive treatment. Diabetes Care 8 337–342, 1985[Abstract]
  5. Schmulling RM, Jakober B, Pfohl M, Overkamp D, Eggstein M: Exercise and insulin requirements. Horm Metab Res Suppl 24: 83–87, 1990[Medline]
  6. Wasserman DH, Geer RJ, Rice DE, Bracy D, Flakoll PJ, Brown LL, Hill JO, Abumrad NN: Interaction of exercise and insulin action in humans. Am J Physiol 260: E37–E45, 1991[Abstract/Free Full Text]
  7. Mauvais-Jarvis F, Kulkarni RN, Kahn CR: Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol (Oxf) 57: 1–9, 2002[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ptjournalHome page
E. A. Gulve
Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy
Physical Therapy, November 1, 2008; 88(11): 1297 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
A. Herbst, R. Bachran, T. Kapellen, R. W. Holl, and for the DPV Science Initiative
Effects of Regular Physical Activity on Control of Glycemia in Pediatric Patients With Type 1 Diabetes Mellitus
Arch Pediatr Adolesc Med, June 1, 2006; 160(6): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
I. W Gallen
Review: Helping the athlete with type 1 diabetes
The British Journal of Diabetes & Vascular Disease, March 1, 2004; 4(2): 87 - 92.
[Abstract] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Gautier, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Gautier, J.-F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum